Cliff Asness's AARD Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 480,249 shares of Aardvark Therapeutics, Inc. (AARD) worth $2.77 M, representing 0.00% of the portfolio. First purchased in 2026-Q1, this recently established position has been held for 2 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in AARD, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2026, adding 345,754 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Aardvark Therapeutics (AARD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Aardvark Therapeutics (AARD) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +345,754 | Add 257.08% | 480,249 | $5.76 |
| Q1 2026 | +134,495 | New Buy | 134,495 | $3.77 |
Cliff Asness's Aardvark Therapeutics Investment FAQs
Cliff Asness first purchased Aardvark Therapeutics, Inc. (AARD) in Q1 2026, acquiring 134,495 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Aardvark Therapeutics, Inc. (AARD) for 2 quarters since Q1 2026.
Cliff Asness's largest addition to Aardvark Therapeutics, Inc. (AARD) was in Q2 2026, adding 480,249 shares worth $2.77 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 480,249 shares of Aardvark Therapeutics, Inc. (AARD), valued at approximately $2.77 M.
As of the Q2 2026 filing, Aardvark Therapeutics, Inc. (AARD) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Aardvark Therapeutics, Inc. (AARD) was 480,249 shares, as reported at the end of Q2 2026.